Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity

International Journal of Hematology

Volumn 90, Issue 3, 2009, Pages 374-377

  Ando, Toshihiko ^a   Mitani, Noriyuki ^a   Matsui, Kumiko ^a   Yamashita, Koji ^a   Nomiyama, Jun ^b   Tsuru, Masatoshi ^a   Yujiri, Toshiaki ^a   Tanizawa, Yukio ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ogoori Daiichi Hospital   (Japan)

Author keywords

Acute myelogenous leukemia; Allogeneic hematopoietic transplantation; CD56; Isolated extramedullary relapse; T(8; 21)

Indexed keywords

CD56 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; FEMUR; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUMBAR VERTEBRA; MALE; STOMACH BIOPSY;

ANTIGENS, CD56; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; GASTRIC MUCOSA; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; RECURRENCE; STOMACH NEOPLASMS; TRANSLOCATION, GENETIC; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 76449088952     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0385-3     Document Type: Article

References (20)

1. AN Békássy J Hermans NC Gorin A Gratwohl 1996 Granulocytic sarcoma after allogeneic bone marrow transplantation, a retrospective European multicenter survey: Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 17 801 808 8733701
2. WY Au YL Kwong AK Lie SK Ma R Liang 1999 Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation Hematol Oncol 17 45 52 10.1002/(SICI)1099-1069(199906)17:2<45::AID-HON641>3.0.CO;2-6 1:STN:280:DyaK1Mvlt1yjsQ%3D%3D 10521868 (Pubitemid 29502312)
3. Y Koc KB Miller DP Schenkein P Daoust K Sprague E Berkman 1999 Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation Cancer 85 608 615 10.1002/(SICI)1097-0142(19990201)85:3<608::AID-CNCR11>3.0.CO;2-5 1:STN:280:DyaK1M7ptVWmtw%3D%3D 10091734 (Pubitemid 29075282)
4. F Ferrara F Morabito B Martino, et al. 2000 CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy J Clin Oncol 18 1295 1300 1:CAS:528:DC%2BD3cXit12ltL0%3D 10715300
5. JD Pancook RA Reisfeld N Varki A Vitiello RI Fox AM Montgomery 1997 Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin J Immunol 158 4413 4421 1:CAS:528:DyaK2sXivVCktL8%3D 9127006
6. D Raspadori D Damiani M Lenoci, et al. 2001 CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis Leukemia 15 1161 1164 10.1038/sj.leu.2402174 1:STN:280:DC%2BD3MvjtlChsA%3D%3D 11480556 (Pubitemid 32776438)
7. M Graf S Reif K Hecht, et al. 2005 High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML) Ann Hematol 84 287 297 10.1007/s00277-004-0978-0 1:CAS:528:DC%2BD2MXivVKhsrw%3D 15592672 (Pubitemid 41166822)
8. JC Byrd RB Weiss DC Arthur, et al. 1997 Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): result from Cancer and Leukemia Group B 8461 J Clin Oncol 15 466 475 1:STN:280:DyaK2s7nvVOgtg%3D%3D 9053467
9. E Di Bona R Sartori R Zambello N Guercini D Madeo F Rodeghiero 2002 Prognostic significance of CD56 antigen expression in acute myeloid leukemia Haematologica 87 250 256 1:CAS:528:DC%2BD38XjtFSjuro%3D 11869936
10. M Schaich R Kock S Soucek R Repp G Ehninger T Illmer 2004 A sensitive model for prediction of relapse in adult acute myeloid leukemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosis Br J Haematol 125 477 479 10.1111/j.1365-2141.2004.04939.x 15142118 (Pubitemid 38916193)
11. M Schaich M Ritter T Illmer, et al. 2001 Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia Br J Haematol 112 300 307 10.1046/j.1365-2141.2001.02562.x 1:CAS:528: DC%2BD3MXhvVaru7o%3D 11167822 (Pubitemid 32183470)
12. D-H Yang J-J Lee Y-C Mun, et al. 2007 Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8;21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation Am J Hematol 82 1 5 10.1002/ajh.20739 1:CAS:528:DC%2BD2sXht12rt7s%3D 16986129 (Pubitemid 46033385)
13. SJ Choi JH Lee S Kim, et al. 2004 Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse Leukemia 18 1789 1797 10.1038/sj.leu.2403523 1:CAS:528:DC%2BD2cXovVGiur8%3D 15385924 (Pubitemid 39530008)
14. A Takami H Okumura H Yamazaki, et al. 2005 Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapse leukemia after allogeneic stem cell transplantation Int J Hematol 82 449 455 10.1532/IJH97.05086 1:CAS:528:DC%2BD28XosVKqsA%3D%3D 16533751 (Pubitemid 46638697)
15. G Chong G Byrnes J Szer A Grigg 2000 Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy Bone Marrow Transplant 26 1011 1015 10.1038/sj.bmt.1702659 1:STN:280:DC%2BD3M7kt1Gnuw%3D%3D 11100282
16. KM Sullivan PL Weiden R Storb, et al. 1989 Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia Blood 74 1720 1728 (Pubitemid 19133213)
17. YZ Jiang JO Cullis EJ Kanfer JM Goldman AJ Barrett 1993 T cell and NK cell-mediated graft-versus-leukemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia Bone Marrow Transplant 11 133 138 1:STN:280:DyaK3s7mvFehsA%3D%3D 8435662
18. C Berthou MC Leglise A Herry, et al. 1998 Extramedullary relapse after favorable molecular response to donor leukocyte infusions for recurring acute leukemia Leukemia 12 1676 1681 10.1038/sj.leu.2401144 1:STN:280: DyaK1M%2FjvFGntA%3D%3D 9823940
19. KY Chiang DJ Weisdorf SM Davies, et al. 1996 Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse Bone Marrow Transplant 17 39 42 1:STN:280:DyaK283nsVSkug%3D%3D 8673052
20. WY Au ACL Chan AKW Lie FE Chen R Liang YL Kwong 1998 Recurrent isolated extramedullary relapses as granulocytic sarcomas following allogeneic bone marrow transplantation for acute myeloid leukemia Bone Marrow Transplant 21 205 208 10.1038/sj.bmt.1701043 1:STN:280:DyaK1c7kvFarsQ%3D%3D 9489639